-
Mannin Research Inc. Presents Data Showing Potential Treatment to Protect Kidney in Acute Kidney Injury Using Mannin Tie2 Activator
Data presented during “Acute Kidney Injury” symposium at the American Society for Nephrology 2019 Annual Meeting Toronto, Canada December 2,2019 Mannin Research Inc.’s (Mannin) Chief Scientific Officer, Dr. Susan Quaggin, presented positive data on a potential new treatment for acute kidney injury (AKI), during the annual Kidney Week meeting, in Washington DC in November 2019. The data suggests that the Angiopoietin-Tie2 signaling pathway is a promising therapeutic target to prevent...
